Sarah Gorey
@sarahgorey.bsky.social
👩🏻⚕️ Geriatric Medicine Fellow 🇮🇪 in 🇺🇸, 🧠Stroke Research & PhD candidate UCD Dublin, 💻MSc NUIG Galway, YSPR committee European Stroke Organisation 🇪🇺
Reposted by Sarah Gorey
For a student with strep throat and an unconfirmed penicillin allergy, would you prescribe a nonpenicillin antibiotic or give penicillin under doctor supervision? Read the case vignette and essays on both treatment options and cast your vote: nej.md/48eHjm9
#MedSky #MedEd
#MedSky #MedEd
October 3, 2025 at 1:03 PM
For a student with strep throat and an unconfirmed penicillin allergy, would you prescribe a nonpenicillin antibiotic or give penicillin under doctor supervision? Read the case vignette and essays on both treatment options and cast your vote: nej.md/48eHjm9
#MedSky #MedEd
#MedSky #MedEd
Reposted by Sarah Gorey
1/ 🚨 NEW #BeyondJournalClub w/ @NEJMGroup: The Bolland study
Question: Does infrequent zoledronate therapy in patients without osteoporosis prevent fractures?
Answer: ⤵️
www.coreimpodcast.com/2025/10/01/b...
Question: Does infrequent zoledronate therapy in patients without osteoporosis prevent fractures?
Answer: ⤵️
www.coreimpodcast.com/2025/10/01/b...
October 1, 2025 at 12:30 PM
1/ 🚨 NEW #BeyondJournalClub w/ @NEJMGroup: The Bolland study
Question: Does infrequent zoledronate therapy in patients without osteoporosis prevent fractures?
Answer: ⤵️
www.coreimpodcast.com/2025/10/01/b...
Question: Does infrequent zoledronate therapy in patients without osteoporosis prevent fractures?
Answer: ⤵️
www.coreimpodcast.com/2025/10/01/b...
Well done @cpkotanidis.bsky.social ! Also check out our manuscript in @annalsofim.bsky.social url.us.m.mimecastprotect.com/s/kNYpCDkAO2...
September 4, 2025 at 7:07 PM
Well done @cpkotanidis.bsky.social ! Also check out our manuscript in @annalsofim.bsky.social url.us.m.mimecastprotect.com/s/kNYpCDkAO2...
Reposted by Sarah Gorey
2.2.1
In an RCT comparing 'uselessly elongated' vs shorter #PeerReview of @neuripsconf.bsky.social 2022 submissions, the longer reviews received higher quality scores, suggesting a length bias among reviewers, w implications for #LLM-generated reviews
journals.plos.org/pl...
@scsatcmu.bsky.social
In an RCT comparing 'uselessly elongated' vs shorter #PeerReview of @neuripsconf.bsky.social 2022 submissions, the longer reviews received higher quality scores, suggesting a length bias among reviewers, w implications for #LLM-generated reviews
journals.plos.org/pl...
@scsatcmu.bsky.social
September 4, 2025 at 3:40 PM
2.2.1
In an RCT comparing 'uselessly elongated' vs shorter #PeerReview of @neuripsconf.bsky.social 2022 submissions, the longer reviews received higher quality scores, suggesting a length bias among reviewers, w implications for #LLM-generated reviews
journals.plos.org/pl...
@scsatcmu.bsky.social
In an RCT comparing 'uselessly elongated' vs shorter #PeerReview of @neuripsconf.bsky.social 2022 submissions, the longer reviews received higher quality scores, suggesting a length bias among reviewers, w implications for #LLM-generated reviews
journals.plos.org/pl...
@scsatcmu.bsky.social
Reposted by Sarah Gorey
In the med literature, statements like “to our knowledge [TOK], this is the FIRST...” often replace a proper systematic search. Among 4488 PMC articles in 6 leading medical journals published 2020-2024, TOK prevalence was 21.7%, w @PLOSMedicine highest (48.4%) and @NEJM lowest (1.3%) #CornellVet
September 4, 2025 at 2:50 PM
In the med literature, statements like “to our knowledge [TOK], this is the FIRST...” often replace a proper systematic search. Among 4488 PMC articles in 6 leading medical journals published 2020-2024, TOK prevalence was 21.7%, w @PLOSMedicine highest (48.4%) and @NEJM lowest (1.3%) #CornellVet
Reposted by Sarah Gorey
The win ratio method is gaining traction in #RCTs. Is it just a trend or a smarter way to look at composite hierarchical outcomes? We break it down in our latest Stats, STAT!📊 in NEJM Evidence. youtube.com/watch?v=jKtF... #stats @nejm.org @sarahgorey.bsky.social @chardin.bsky.social @ai.nejm.org
How Win Ratios Work | NEJM Evidence
YouTube video by NEJM Group
youtube.com
July 31, 2025 at 11:41 AM
The win ratio method is gaining traction in #RCTs. Is it just a trend or a smarter way to look at composite hierarchical outcomes? We break it down in our latest Stats, STAT!📊 in NEJM Evidence. youtube.com/watch?v=jKtF... #stats @nejm.org @sarahgorey.bsky.social @chardin.bsky.social @ai.nejm.org
Reposted by Sarah Gorey
Irish whale watching business closes after 25 years. 🐳
“There are only a few whales left - the water is overfished.”
The owner was previously a commercial fisher but gave up when fish stocks crashed. “It wasn’t something I wanted to be a part of.” 🎣❌
www.irishtimes.com/ireland/2025...
“There are only a few whales left - the water is overfished.”
The owner was previously a commercial fisher but gave up when fish stocks crashed. “It wasn’t something I wanted to be a part of.” 🎣❌
www.irishtimes.com/ireland/2025...
‘It’s an empty, lifeless sea’: Whales leave Cork waters, putting watchers out of business
Stocks of sprat have crashed, forcing whales away, says businessman whose livelihood has been ruined
www.irishtimes.com
June 2, 2025 at 11:42 AM
Irish whale watching business closes after 25 years. 🐳
“There are only a few whales left - the water is overfished.”
The owner was previously a commercial fisher but gave up when fish stocks crashed. “It wasn’t something I wanted to be a part of.” 🎣❌
www.irishtimes.com/ireland/2025...
“There are only a few whales left - the water is overfished.”
The owner was previously a commercial fisher but gave up when fish stocks crashed. “It wasn’t something I wanted to be a part of.” 🎣❌
www.irishtimes.com/ireland/2025...
🐈🐕📈📉👩💻🛋️
The latest Stats, STAT! animated video from NEJM Evidence describes the use of restricted mean survival time in survival analysis when the proportional hazards assumption is not met.
📺 Full video and transcript: eviden.cc/42YS8FQ
#StatsSky #Statistics
📺 Full video and transcript: eviden.cc/42YS8FQ
#StatsSky #Statistics
May 28, 2025 at 11:12 PM
🐈🐕📈📉👩💻🛋️
Reposted by Sarah Gorey
In the BATURA trial, as-needed albuterol–budesonide resulted in a lower risk of severe asthma exacerbation than as-needed albuterol among participants with disease that was uncontrolled despite treatment for mild asthma. Full trial results: nej.md/43uVpwK
#ATS2025 @atscommunity.bsky.social
#ATS2025 @atscommunity.bsky.social
May 19, 2025 at 4:25 PM
In the BATURA trial, as-needed albuterol–budesonide resulted in a lower risk of severe asthma exacerbation than as-needed albuterol among participants with disease that was uncontrolled despite treatment for mild asthma. Full trial results: nej.md/43uVpwK
#ATS2025 @atscommunity.bsky.social
#ATS2025 @atscommunity.bsky.social
Reposted by Sarah Gorey
BRIDGE-TNK trial: Among 550 patients with stroke due to large-vessel occlusion who had presented within 4.5 hours after onset, 90-day functional outcomes were better with intravenous tenecteplase before thrombectomy than with thrombectomy alone. nej.md/3GTVKAk
#ESOC2025 @esostroke.bsky.social
#ESOC2025 @esostroke.bsky.social
May 21, 2025 at 8:04 AM
BRIDGE-TNK trial: Among 550 patients with stroke due to large-vessel occlusion who had presented within 4.5 hours after onset, 90-day functional outcomes were better with intravenous tenecteplase before thrombectomy than with thrombectomy alone. nej.md/3GTVKAk
#ESOC2025 @esostroke.bsky.social
#ESOC2025 @esostroke.bsky.social
Really enjoying @cpkotanidis.bsky.social’s fascinating presentation on his interesting work at @brighamandwomens.bsky.social on identifying risk markers of CVD in patients with IMIDs 🤩👏👏👏
May 6, 2025 at 8:30 PM
Really enjoying @cpkotanidis.bsky.social’s fascinating presentation on his interesting work at @brighamandwomens.bsky.social on identifying risk markers of CVD in patients with IMIDs 🤩👏👏👏
Reposted by Sarah Gorey
For a woman with device-detected atrial fibrillation, would you initiate anticoagulant therapy or recommend continuation of antiplatelet therapy? Read the case vignette and essays on both treatment options and cast your vote: nej.md/4lQzxTA
#MedSky #CardioSky #Afib
#MedSky #CardioSky #Afib
May 2, 2025 at 7:10 PM
For a woman with device-detected atrial fibrillation, would you initiate anticoagulant therapy or recommend continuation of antiplatelet therapy? Read the case vignette and essays on both treatment options and cast your vote: nej.md/4lQzxTA
#MedSky #CardioSky #Afib
#MedSky #CardioSky #Afib
Reposted by Sarah Gorey
Both clonal hematopoiesis of indeterminate potential (CHIP) and cancer are more common with age. When they coexist in the same patient, CHIP cells may migrate to the tumor and have an adverse effect on overall survival. Full study results: nej.md/3EnzMVu
#MedSky #Hematology
#MedSky #Hematology
April 27, 2025 at 1:21 PM
Both clonal hematopoiesis of indeterminate potential (CHIP) and cancer are more common with age. When they coexist in the same patient, CHIP cells may migrate to the tumor and have an adverse effect on overall survival. Full study results: nej.md/3EnzMVu
#MedSky #Hematology
#MedSky #Hematology
Reposted by Sarah Gorey
Our partnership with @glaucomflecken.bsky.social continues as he summarizes new research into fracture prevention with infrequent zoledronate in women 50 to 60 years of age. Access the article for free: nej.md/DrG15
#MedSky
#MedSky
April 22, 2025 at 7:03 PM
Our partnership with @glaucomflecken.bsky.social continues as he summarizes new research into fracture prevention with infrequent zoledronate in women 50 to 60 years of age. Access the article for free: nej.md/DrG15
#MedSky
#MedSky
Reposted by Sarah Gorey
A 56-year-old man was transferred to a burn center for management of pavement burns on his feet that had occurred during a heat wave. Read the full case details: nej.md/3Rh2XfR
@uwsph.bsky.social #MedSky #ClimateChange
@uwsph.bsky.social #MedSky #ClimateChange
April 22, 2025 at 12:12 PM
A 56-year-old man was transferred to a burn center for management of pavement burns on his feet that had occurred during a heat wave. Read the full case details: nej.md/3Rh2XfR
@uwsph.bsky.social #MedSky #ClimateChange
@uwsph.bsky.social #MedSky #ClimateChange
Reposted by Sarah Gorey
New research alert: Our latest report highlights a significant reduction in coronary #inflammation and residual inflammatory risk as captured by #CCTA imaging using CaRi-Heart AI in women with #BreastCancer 2 years post-RT
#AI #CardioOncology #CardioEd #EHJ
@escardio.bsky.social
#AI #CardioOncology #CardioEd #EHJ
@escardio.bsky.social
Coronary inflammation and cardiovascular risk in breast cancer after radiotherapy
Radiotherapy (RT) is known to reduce the rate of disease recurrence following breast-conserving surgery in patients with breast cancer, but also entails ir
academic.oup.com
April 22, 2025 at 1:57 PM
New research alert: Our latest report highlights a significant reduction in coronary #inflammation and residual inflammatory risk as captured by #CCTA imaging using CaRi-Heart AI in women with #BreastCancer 2 years post-RT
#AI #CardioOncology #CardioEd #EHJ
@escardio.bsky.social
#AI #CardioOncology #CardioEd #EHJ
@escardio.bsky.social
Reposted by Sarah Gorey
1/ 🚨 NEW #BeyondJournalClub w/ @NEJMGroup: PURPOSE Trials
Both PURPOSE 1 & 2 used a new long acting medication: Lenacapavir!
Let’s learn what we can takeaway from these trials ⤵️
🖥️: coreimpodcast.com/2025/04/16/a-r…
Both PURPOSE 1 & 2 used a new long acting medication: Lenacapavir!
Let’s learn what we can takeaway from these trials ⤵️
🖥️: coreimpodcast.com/2025/04/16/a-r…
April 16, 2025 at 11:54 AM
1/ 🚨 NEW #BeyondJournalClub w/ @NEJMGroup: PURPOSE Trials
Both PURPOSE 1 & 2 used a new long acting medication: Lenacapavir!
Let’s learn what we can takeaway from these trials ⤵️
🖥️: coreimpodcast.com/2025/04/16/a-r…
Both PURPOSE 1 & 2 used a new long acting medication: Lenacapavir!
Let’s learn what we can takeaway from these trials ⤵️
🖥️: coreimpodcast.com/2025/04/16/a-r…
Reposted by Sarah Gorey
An outstanding episode - learned a ton 🥂
1/ 🚨 NEW #5Pearls: Lp(a) and ASCVD Risk
Lp(a) is a lipoprotein similar to LDL but a different entity!
Lp(a) has important implications for cardiovascular disease ‼️
🖥️: coreimpodcast.com/2025/04/02/lpa…
Sponsor: Freed AI
Lp(a) is a lipoprotein similar to LDL but a different entity!
Lp(a) has important implications for cardiovascular disease ‼️
🖥️: coreimpodcast.com/2025/04/02/lpa…
Sponsor: Freed AI
April 2, 2025 at 2:07 PM
An outstanding episode - learned a ton 🥂
Reposted by Sarah Gorey
Editorial: Cancer-Associated Venous Thromboembolism — Beyond 6 Months nej.md/4iB6wcA
March 29, 2025 at 2:35 PM
Editorial: Cancer-Associated Venous Thromboembolism — Beyond 6 Months nej.md/4iB6wcA
Reposted by Sarah Gorey
Ever wondered how interim analyses work in #RCTs? 📊 Check out our Stats, STAT! video at NEJM Evidence: @nejm.org @ai.nejm.org @sarahgorey.bsky.social evidence.nejm.org/doi/full/10.... #MedStats #ClinicalTrials
How Interim Analyses Work
This Stats, STAT! animated video explores interim analyses in clinical trials. During
these evaluations of the data, researchers may assess safety, efficacy, and verify
sample size assumptions, but...
evidence.nejm.org
March 26, 2025 at 2:09 PM
Ever wondered how interim analyses work in #RCTs? 📊 Check out our Stats, STAT! video at NEJM Evidence: @nejm.org @ai.nejm.org @sarahgorey.bsky.social evidence.nejm.org/doi/full/10.... #MedStats #ClinicalTrials
Reposted by Sarah Gorey
What is the impact of microplastics on human health? The latest episode of Beyond Journal Club, a collaboration between @coreimpodcast.bsky.social and NEJM Group, takes a deep dive into the APAChE study on microplastics and cardiovascular disease. 🎧 Listen here: nej.md/4igpJQy
#MedSky
#MedSky
March 18, 2025 at 7:30 PM
What is the impact of microplastics on human health? The latest episode of Beyond Journal Club, a collaboration between @coreimpodcast.bsky.social and NEJM Group, takes a deep dive into the APAChE study on microplastics and cardiovascular disease. 🎧 Listen here: nej.md/4igpJQy
#MedSky
#MedSky
Reposted by Sarah Gorey
The SCALE Kids trial, summarized here by NEJM Editorial Fellow Harleen Marwah, MD, assessed the efficacy and safety of liraglutide, as compared with placebo, as an adjunct treatment to lifestyle interventions, for the treatment of obesity in children 6 to 12 years of age. Full trial: nej.md/3MBP1uc
March 14, 2025 at 8:40 PM
The SCALE Kids trial, summarized here by NEJM Editorial Fellow Harleen Marwah, MD, assessed the efficacy and safety of liraglutide, as compared with placebo, as an adjunct treatment to lifestyle interventions, for the treatment of obesity in children 6 to 12 years of age. Full trial: nej.md/3MBP1uc
A great listen from the coreIM team on potential health effects of microplastics and a nuanced discussion on causality and limitations of observational studies ❤️👏🐥
1/ 🚨 NEW #BeyondJournalClub w/ @NEJMGroup: The APACHE Study ⤵️
We gave a sneak peak the other day, but now let’s dive into it 🌊
🖥️: coreimpodcast.com/2025/03/05/mic…
We gave a sneak peak the other day, but now let’s dive into it 🌊
🖥️: coreimpodcast.com/2025/03/05/mic…
March 5, 2025 at 2:37 PM
A great listen from the coreIM team on potential health effects of microplastics and a nuanced discussion on causality and limitations of observational studies ❤️👏🐥
Reposted by Sarah Gorey
A truly beautiful piece by Dr Lisa McNamee (@lisadangermcnamee.bsky.social)!
Everyone should read this!
Everyone should read this!
Turning despair into action - Medical Independent
In January, climate action advocate and Dundalk GP Dr Seán Owens was seriously injured while cycling home from work...
www.medicalindependent.ie
February 25, 2025 at 9:48 AM
A truly beautiful piece by Dr Lisa McNamee (@lisadangermcnamee.bsky.social)!
Everyone should read this!
Everyone should read this!
Reposted by Sarah Gorey
"By staying true to its mission and embracing necessary reforms, PEPFAR can...continue to be a beacon of hope in the fight against HIV/AIDS."
Comment—PEPFAR under review: what's at stake for PEPFAR's future tinyurl.com/28ahdmv8 #MedSky
Comment—PEPFAR under review: what's at stake for PEPFAR's future tinyurl.com/28ahdmv8 #MedSky
PEPFAR under review: what's at stake for PEPFAR's future
The US President's Emergency Plan for AIDS Relief (PEPFAR) faces a pivotal moment,
confronting one of its most challenging periods since its launch in 2003. The new
policy priorities of the administra...
tinyurl.com
February 25, 2025 at 2:38 PM
"By staying true to its mission and embracing necessary reforms, PEPFAR can...continue to be a beacon of hope in the fight against HIV/AIDS."
Comment—PEPFAR under review: what's at stake for PEPFAR's future tinyurl.com/28ahdmv8 #MedSky
Comment—PEPFAR under review: what's at stake for PEPFAR's future tinyurl.com/28ahdmv8 #MedSky